Stonegate Capital Partners updates coverage on Nu Skin Enterprises, reporting Q4 2025 results with $370.3M revenue, $0.29 EPS, and strategic focus on India expansionStonegate Capital Partners updates coverage on Nu Skin Enterprises, reporting Q4 2025 results with $370.3M revenue, $0.29 EPS, and strategic focus on India expansion

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Following Q4 Results

2026/02/13 22:32
2 min read

Stonegate Capital Partners has updated its coverage of NU Skin Enterprises Inc. following the company’s fourth-quarter financial results. NU Skin reported revenue of $370.3 million, adjusted net income of $14.5 million, and adjusted earnings per share of $0.29 for the period. These figures came in slightly below Stonegate’s estimates of $380.2 million in revenue, $15.1 million in adjusted net income, and $0.30 in adjusted EPS, but management noted the results were at the low end of revenue guidance and the high end of EPS guidance.

The company’s Rhyz segment contributed $48.52 million in revenue, with $42.45 million coming from manufacturing and $6.07 million from other Rhyz operations. Meanwhile, the core Nu Skin business maintained a gross margin of 77.6% and benefited from disciplined spending as selling expenses declined to 40.8% of the core business. Management highlighted several factors contributing to the earnings results, including strategic penetration into India and other emerging markets, overall margin expansion, and a one-time tax benefit during fiscal year 2025.

Despite revenue coming in weaker than expected, NU Skin’s leadership emphasized continued focus on executing strategic initiatives. The company is advancing the rollout of its Prism iO platform in the first half of 2026 and has an India pre-launch underway with full market opening expected in the second half of 2026. For the full fiscal year 2026, management provided EPS guidance with a midpoint of $1.00, signaling confidence in the company’s strategic direction despite current revenue challenges.

The update from Stonegate Capital Partners provides investors with analysis of NU Skin’s performance and strategic positioning. The firm noted that while top-line results were below expectations, the company’s margin discipline and international expansion efforts, particularly in emerging markets like India, represent important growth drivers. The full research announcement, including downloadable images and additional details, is available through Stonegate’s reporting platform. Investors can access the complete analysis to view the full announcement for more comprehensive coverage of NU Skin’s financial position and strategic outlook.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by Reportable. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Following Q4 Results.

The post Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Following Q4 Results appeared first on citybuzz.

Market Opportunity
IO Logo
IO Price(IO)
$0,1042
$0,1042$0,1042
+1,26%
USD
IO (IO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags: